Sep. 16, 2009 (PR Newswire) --
EXTON, Pa., Sept. 16 /PRNewswire-FirstCall/ -- Kensey Nash Corporation (Nasdaq: KNSY) is scheduled to present at the 2009 UBS Global Life Sciences conference at the Grand Hyatt New York in New York City on Monday, September 21, 2009.
Joseph W. Kaufmann, Kensey Nash's President & CEO, will deliver the Company's presentation, beginning at approximately 12:30 p.m. (ET). To hear the live webcast of the Kensey Nash presentation at the UBS Global Life Sciences conference, go to http://cc.talkpoint.com/ubsx001/092109a_ke/?entity=73_ERFV1QW and access the conference link. The presentation materials will also be available on the company's website (www.kenseynash.com) beginning at 12:30 p.m. (ET) on Monday, September 21, 2009.
About Kensey Nash Corporation. Kensey Nash Corporation is a leader in developing, manufacturing and processing resorbable biomaterial products, incorporating its proprietary collagen and synthetic polymer technology. This expertise is used to develop and commercialize its products through strategic partners. The company has an extensive range of products, which are sold in multiple medical markets, including, the cardiology, orthopedic, sports medicine, spine, endovascular and general surgery markets. The company is known as a pioneer in the field of arterial puncture closure, as the inventor and developer of the Angio-Seal Vascular Closure Device, which is licensed to St. Jude Medical, Inc.
SOURCE Kensey Nash Corporation
